{
  "data": {
    "indicator": {
      "slug": "pharmaceutical-sales-revenue",
      "name": "Pharmaceutical sales revenue",
      "definition": "Total sales revenue generated from pharmaceutical and healthcare products.",
      "unit": "GBP",
      "scale": "billion",
      "default_unit": "GBP",
      "default_scale": "billion"
    },
    "scale": "billion",
    "unit": "GBP",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2026-04-01",
        "period_label": "Q2 2026",
        "value": 8.4,
        "scale": "billion",
        "unit": "GBP",
        "value_type": "actual",
        "statistic_id": "stat_NAZF6DZ1XTDSKBY9NBTYVHJ7NE",
        "url": "https://statorigin.org/stat/stat_NAZF6DZ1XTDSKBY9NBTYVHJ7NE",
        "source_org": "GSK",
        "source": {
          "org": "GSK",
          "org_short_name": "GSK",
          "document_title": "GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026",
          "document_url": "https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q2-core-results-performance-and-continued-momentum/",
          "locator": "Strong Specialty Medicines and Vaccines performance drives sales and core operating profit growth",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}